These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 9043025

  • 1. Prediction of recurrence by quantification of p185neu protein in non-small-cell lung cancer tissue.
    Diez M, Pollán M, Maestro M, Torres A, Ortega D, Gómez A, Sánchez A, Hernando F, Balibrea JL.
    Br J Cancer; 1997; 75(5):684-9. PubMed ID: 9043025
    [Abstract] [Full Text] [Related]

  • 2. Use of possible synergistic expression of p53 and p185 as a prognostic tool for stage I non-small-cell lung cancer.
    Cantero R, Torres AJ, Maestro M, Fernández C, Hernando F, del Barco V, Sanz T, Balibrea JL.
    World J Surg; 1999 Dec; 23(12):1294-9; discussion 1299-300. PubMed ID: 10552124
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of the quantified expression of p185 in non-small cell lung cancer.
    Cantero R, Torres AJ, Maestro ML, Hernando F, Sanz MT, Del Barco V, Gómez A, Fernández C, Balibrea JL.
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1119-25. PubMed ID: 10838527
    [Abstract] [Full Text] [Related]

  • 4. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.
    Schneider PM, Praeuer HW, Stoeltzing O, Boehm J, Manning J, Metzger R, Fink U, Wegerer S, Hoelscher AH, Roth JA.
    Br J Cancer; 2000 Aug; 83(4):473-9. PubMed ID: 10945494
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Her-2 amplification and p185 expression in invasive breast cancer cells in women].
    Titi S.
    Ann Acad Med Stetin; 2006 Aug; 52(2):5-12. PubMed ID: 17633393
    [Abstract] [Full Text] [Related]

  • 10. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
    Nguyen XC, Lee WW, Chung JH, Park SY, Sung SW, Kim YK, So Y, Lee DS, Chung JK, Lee MC, Kim SE.
    Eur J Radiol; 2007 May; 62(2):214-9. PubMed ID: 17239556
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
    Tsai CM, Levitzki A, Wu LH, Chang KT, Cheng CC, Gazit A, Perng RP.
    Cancer Res; 1996 Mar 01; 56(5):1068-74. PubMed ID: 8640763
    [Abstract] [Full Text] [Related]

  • 13. New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer.
    Melloni G, Gajate AM, Sestini S, Gallivanone F, Bandiera A, Landoni C, Muriana P, Gianolli L, Zannini P.
    Eur J Surg Oncol; 2013 Nov 01; 39(11):1254-61. PubMed ID: 23948705
    [Abstract] [Full Text] [Related]

  • 14. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
    Wang Y, Zhang XR, Fu J, Tan W, Zhang W.
    Zhonghua Zhong Liu Za Zhi; 2004 Jun 01; 26(6):369-72. PubMed ID: 15312350
    [Abstract] [Full Text] [Related]

  • 15. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.
    Allgayer H, Babic R, Gruetzner KU, Tarabichi A, Schildberg FW, Heiss MM.
    J Clin Oncol; 2000 Jun 01; 18(11):2201-9. PubMed ID: 10829039
    [Abstract] [Full Text] [Related]

  • 16. Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non-Small-Cell Lung Cancer: Study Protocol.
    Ohashi K, Hotta K, Hirata T, Aoe K, Kozuki T, Ninomiya K, Kayatani H, Yanai H, Toyooka S, Hinotsu S, Takata M, Kiura K.
    Clin Lung Cancer; 2017 Jan 01; 18(1):92-95. PubMed ID: 27497829
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
    Lee JW, Na JO, Kang DY, Lee SY, Lee SM.
    Clin Lung Cancer; 2017 Mar 01; 18(2):198-206. PubMed ID: 27495385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.